Evidence map›Paper›PMID 12707053›Full record

ArticleThe American journal of pathology2003

Regeneration of transgenic skeletal muscles with altered timing of expression of the basic helix-loop-helix muscle regulatory factor MRF4.

Grace K Pavlath, Janice A Dominov, Kristy M Kegley, Jeffrey Boone Miller

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Gene therapy for inherited muscle diseases: where genetics meets rehabilitation medicine.American journal of physical medicine & rehabilitation · 2014
    Review
  10. Article
  11. Article
  12. Article
  13. Regulatory interactions between muscle and the immune system during muscle regeneration.American journal of physiology. Regulatory, integrative and comparative physiology · 2010
    Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Grace K PavlathDepartment of Pharmacology, Emory University School of Medicine, Atlanta, Georgia, USA.
Janice A Dominov
Kristy M Kegley
Jeffrey Boone Miller
Boston Biomedical Research Institute · USEmory University · US

Funding

NEUROTOXICOGENOMICS AND CHILD HEALTHU19ES011384 · NIEHS · OREGON HEALTH & SCIENCE UNIVERSITY · PI SPENCER, PETER S · 2001 to 2006
$8.7M
MOLECULAR PHYSIOLOGY OF RESPIRATORY MUSCLESR01HL064641 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MILLER, JEFFREY BOONE · 2000 to 2010
$4.8M
Molecular Physiology of Recovery from Muscle AtrophyR01AR047314 · NIAMS · EMORY UNIVERSITY · PI PAVLATH, GRACE K · 2001 to 2012
$3.0M
ENHANCED TISSUE REGENERATION OF OROFACIAL MUSCLESR01DE013040 · NIDCR · EMORY UNIVERSITY · PI PAVLATH, GRACE K · 1998 to 2002
$924k
THE ROLE OF BCL-2 IN SKELETAL MUSCLE STEM CELLSR03AR045840 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI DOMINOV, JANICE A · 1998 to 2000
$83k
MRF IN DEVELOPMENT OF CELL PHENOTYPER01AR043565 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI MILLER, JEFFREY BOONE · 1995 to 1998
–
INFLAMMATORY MEDIATORS IN MASTICATORY MUSCLESR01DE011987 · NIDCR · EMORY UNIVERSITY · PI PAVLATH, GRACE K · 1996 to 1999
–
NHLBI NIH HHS HL64641NHLBI NIH HHS R01 HL064641NIAMS NIH HHS AR43565NIAMS NIH HHS AR45840NIAMS NIH HHS AR47314NIAMS NIH HHS R01 AR047314NIDCR NIH HHS DE11987NIDCR NIH HHS DE13040NIEHS NIH HHS ES11384NIEHS NIH HHS U19 ES011384
6 · The paper itself

Abstract

In regenerating muscle cells, muscle regulatory factor (MRF) 4 is normally the last of the four MRFs to be expressed. To analyze how the timing of MRF4 expression affects muscle regeneration, we compared regeneration after local freeze injury of muscles from wild-type mice with muscles from transgenic mice in which MRF4 expression was under control of an approximately 1.6-kb fragment of the myogenin promoter. Three days after injury, masseter and tibialis anterior (TA) muscles in wild-type mice expressed little or no MRF4 mRNA; whereas these muscles in transgenic mice expressed abundant MRF4 mRNA from both the transgene and the endogenous gene. Thus, MRF4 up-regulation was accelerated in transgenic compared to wild-type regenerating muscles, and expression of the transgene appeared to activate, perhaps indirectly, expression of the endogenous MRF4 gene. At 11 days after injury, regeneration, as measured by cross-sectional area and density of regenerated fibers, was significantly impaired in transgenic TA compared to wild-type TA, whereas at 19 days after injury both transgenic and TA muscle fibers had fully recovered to preinjury values. Regeneration of masseter muscles, which normally regenerate much less completely than TA muscles, was unaffected by the transgene. Thus, the timing of MRF4 up-regulation, as well as additional muscle-specific factors, can determine the progress of muscle regeneration.

Indexed as

AnimalsGene Expression RegulationHelix-Loop-Helix MotifsMiceMice, TransgenicMuscle, SkeletalMyogenic Regulatory FactorsMyogeninPromoter Regions, GeneticRatsRegenerationWound Healingmyogenic factor 6Myogenic Regulatory FactorsMyogeninMyog protein, mouseMyog protein, rat

Identifiers

PMID12707053
PMCPMC1851175
OpenAlexW1972651851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.